BRYAN, Texas, Feb. 16, 2021 (Globe NEWSWIRE) — iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics deal production corporation, right now
BRYAN, Texas, Feb. 16, 2021 (Globe NEWSWIRE) — iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics deal production corporation, right now